Immix Biopharma, Inc. SEC filings IMMX
Immix Biopharma, Inc. has 244 filings in SEC EDGAR's recent list, going back to Jul 20, 2021. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 27, 2026 | — |
| 8-K |
Current report
Other events
|
Sep 30, 2026 | Sep 29, 2026 |
| FWP | Free writing prospectus | Sep 29, 2026 | — |
| 424B5 | Prospectus supplement | Sep 29, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 29, 2026 | Sep 29, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Jul 20, 2026 | Jul 20, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 5, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 8-K |
Current report
Other events
|
May 21, 2026 | May 21, 2026 |
| 424B5 | Prospectus supplement | May 21, 2026 | — |
| FWP | Free writing prospectus | May 21, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 21, 2026 | May 21, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 4, 2026 | — |
| ARS | Annual report to shareholders | Apr 6, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 6, 2026 | — |
| DEF 14A | Proxy statement | Apr 6, 2026 | Apr 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 30, 2026 | Mar 30, 2026 |
| 10-K/A | Amended annual report | Mar 27, 2026 | Dec 31, 2025 |
| S-8 | Employee stock plan registration | Mar 25, 2026 | — |
| 8-K |
Current report
Material agreement
|
Mar 25, 2026 | Mar 25, 2026 |
| 424B5 | Prospectus supplement | Mar 25, 2026 | — |
| 10-K | Annual report | Mar 25, 2026 | Dec 31, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 20, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| EFFECT | Filing | Jan 22, 2026 | — |
| CORRESP | Letter to the SEC | Jan 16, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2026 | — |
| S-3 | Shelf registration | Jan 9, 2026 | — |
| 4 | Insider transaction | Dec 11, 2025 | Nov 21, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Material agreement
|
Dec 8, 2025 | Dec 7, 2025 |
| 424B5 | Prospectus supplement | Dec 8, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 8, 2025 | Dec 7, 2025 |
| FWP | Free writing prospectus | Dec 8, 2025 | — |
| EFFECT | Filing | Dec 1, 2025 | — |
| CORRESP | Letter to the SEC | Nov 26, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 26, 2025 | Nov 26, 2025 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| S-3 | Shelf registration | Oct 6, 2025 | — |
| 4 | Insider transaction | Sep 17, 2025 | Sep 17, 2025 |
| 4 | Insider transaction | Sep 17, 2025 | Sep 16, 2025 |
| 3 | Initial insider ownership | Sep 17, 2025 | Sep 8, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Sep 8, 2025 | Sep 5, 2025 |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 424B5 | Prospectus supplement | Jun 3, 2025 | — |
| 8-K |
Current report
Material agreement
|
Jun 3, 2025 | Jun 3, 2025 |
| ARS | Annual report to shareholders | May 19, 2025 | Dec 31, 2024 |
| 10-Q/A | Amended quarterly report | May 19, 2025 | Mar 31, 2025 |
| DEFA14A | Additional proxy material | May 19, 2025 | — |
| 10-K/A | Amended annual report | May 19, 2025 | Dec 31, 2024 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| DEFA14A | Additional proxy material | May 5, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Apr 29, 2025 |
| 10-K | Annual report | Mar 25, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 29, 2025 | — |
| 4 | Insider transaction | Dec 26, 2024 | Dec 20, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Aug 26, 2024 | Aug 21, 2024 |
| 4 | Insider transaction | Aug 19, 2024 | Aug 16, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jul 31, 2024 | Jul 18, 2024 |
| 8-K |
Current report
Other events
|
Jul 26, 2024 | Jul 25, 2024 |
| 8-K |
Current report
Auditor change
|
Jul 22, 2024 | Jul 17, 2024 |
| S-8 | Employee stock plan registration | Jul 22, 2024 | — |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 14, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 4, 2024 |
| DEFA14A | Additional proxy material | May 21, 2024 | — |
| 8-K |
Current report
Unregistered share sale, Other events
|
May 20, 2024 | May 20, 2024 |
| D | Filing | May 20, 2024 | — |
| 4 | Insider transaction | May 20, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 20, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 20, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 14, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | Apr 30, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 29, 2024 | Apr 29, 2024 |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| S-8 | Employee stock plan registration | Feb 20, 2024 | — |
| 424B5 | Prospectus supplement | Feb 7, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 7, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Feb 6, 2024 | Feb 6, 2024 |
| 424B5 | Prospectus supplement | Feb 5, 2024 | — |
| 8-K |
Current report
Other events
|
Feb 5, 2024 | Feb 5, 2024 |
| 4 | Insider transaction | Dec 12, 2023 | Dec 8, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 4/A | Filing | Nov 9, 2023 | Aug 14, 2023 |
| 4/A | Filing | Nov 9, 2023 | Aug 14, 2023 |
| EFFECT | Filing | Sep 28, 2023 | — |
| CORRESP | Letter to the SEC | Sep 26, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2023 | — |
| S-3 | Shelf registration | Sep 25, 2023 | — |
| 4 | Insider transaction | Sep 18, 2023 | Sep 11, 2023 |
| 4 | Insider transaction | Sep 15, 2023 | Sep 14, 2023 |
| 4 | Insider transaction | Sep 14, 2023 | Sep 12, 2023 |
| 4 | Insider transaction | Sep 12, 2023 | Sep 8, 2023 |
| 4 | Insider transaction | Sep 11, 2023 | Sep 7, 2023 |
| 4 | Insider transaction | Sep 8, 2023 | Sep 6, 2023 |
| 4 | Insider transaction | Sep 6, 2023 | Sep 5, 2023 |
| 4 | Insider transaction | Sep 5, 2023 | Aug 31, 2023 |
| SC 13D | Ownership over 5% (active) | Aug 30, 2023 | — |
| 4 | Insider transaction | Aug 23, 2023 | Aug 22, 2023 |
| 3 | Initial insider ownership | Aug 23, 2023 | Aug 22, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Aug 22, 2023 | Aug 22, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 424B5 | Prospectus supplement | Jul 14, 2023 | — |
| 8-K |
Current report
Material agreement
|
Jul 14, 2023 | Jul 14, 2023 |
| S-8 | Employee stock plan registration | Jun 13, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2023 | Jun 7, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2023 | — |
| ARS | Annual report to shareholders | Apr 25, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 25, 2023 | Apr 25, 2023 |
| 10-K | Annual report | Mar 27, 2023 | Dec 31, 2022 |
| 424B5 | Prospectus supplement | Mar 22, 2023 | — |
| 8-K |
Current report
Material agreement
|
Mar 22, 2023 | Mar 22, 2023 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Material agreement
|
Mar 13, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 18, 2023 | Jan 12, 2023 |
| EFFECT | Filing | Jan 11, 2023 | — |
| CORRESP | Letter to the SEC | Jan 9, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 6, 2023 | — |
| S-3 | Shelf registration | Jan 3, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 16, 2022 | Dec 16, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 14, 2022 | Dec 8, 2022 |
| 4 | Insider transaction | Nov 15, 2022 | Nov 14, 2022 |
| 4 | Insider transaction | Nov 15, 2022 | Nov 14, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 4/A | Filing | Jul 22, 2022 | Jul 14, 2022 |
| RW | Filing | Jul 19, 2022 | — |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| RW WD | Filing | Jun 30, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2022 | Jun 8, 2022 |
| FWP | Free writing prospectus | May 27, 2022 | — |
| S-1 | Registration statement | May 27, 2022 | — |
| DRS | Filing | May 24, 2022 | — |
| 10-Q | Quarterly report | May 13, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 25, 2022 | — |
| DEF 14A | Proxy statement | Apr 25, 2022 | Apr 25, 2022 |
| 10-K | Annual report | Mar 28, 2022 | Dec 31, 2021 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 2, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2022 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMMX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Angeles, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1873835
- Former names
- Immix Biopharma, Inc. (until Oct 27, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.